176 related articles for article (PubMed ID: 22864395)
1. A knockdown of Maml1 that results in melanoma cell senescence promotes an innate and adaptive immune response.
Kang S; Xie J; Miao J; Li R; Liao W; Luo R
Cancer Immunol Immunother; 2013 Jan; 62(1):183-90. PubMed ID: 22864395
[TBL] [Abstract][Full Text] [Related]
2. Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming.
Steele L; Errington F; Prestwich R; Ilett E; Harrington K; Pandha H; Coffey M; Selby P; Vile R; Melcher A
Mol Cancer; 2011 Feb; 10():20. PubMed ID: 21338484
[TBL] [Abstract][Full Text] [Related]
3. MAML1 promotes ESCC aggressiveness through upregulation of EMT marker TWIST1.
Forghanifard MM; Azaraz S; Ardalan Khales S; Morshedi Rad D; Abbaszadegan MR
Mol Biol Rep; 2020 Apr; 47(4):2659-2668. PubMed ID: 32180088
[TBL] [Abstract][Full Text] [Related]
4. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.
Fan T; Jiang S; Chung N; Alikhan A; Ni C; Lee CC; Hornyak TJ
Mol Cancer Res; 2011 Apr; 9(4):418-29. PubMed ID: 21383005
[TBL] [Abstract][Full Text] [Related]
5. IL-15 has innate anti-tumor activity independent of NK and CD8 T cells.
Davies E; Reid S; Medina MF; Lichty B; Ashkar AA
J Leukoc Biol; 2010 Sep; 88(3):529-36. PubMed ID: 20538758
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of MAML1 inhibits proliferation and induces apoptosis of T-cell acute lymphoblastic leukemia cells through SP1-dependent inactivation of TRIM59.
Cheng H; Chen L; Hu X; Qiu H; Xu X; Gao L; Tang G; Zhang W; Wang J; Yang J; Huang C
J Cell Physiol; 2019 Apr; 234(4):5186-5195. PubMed ID: 30370525
[TBL] [Abstract][Full Text] [Related]
7. Induction of CCL2 by siMAML1 through upregulation of TweakR in melanoma cells.
Kang S; Yang C; Luo R
Biochem Biophys Res Commun; 2008 Aug; 372(4):629-33. PubMed ID: 18503747
[TBL] [Abstract][Full Text] [Related]
8. Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade.
Benci JL; Johnson LR; Choa R; Xu Y; Qiu J; Zhou Z; Xu B; Ye D; Nathanson KL; June CH; Wherry EJ; Zhang NR; Ishwaran H; Hellmann MD; Wolchok JD; Kambayashi T; Minn AJ
Cell; 2019 Aug; 178(4):933-948.e14. PubMed ID: 31398344
[TBL] [Abstract][Full Text] [Related]
9. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.
Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S
J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578
[TBL] [Abstract][Full Text] [Related]
10. Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment.
Vilgelm AE; Johnson CA; Prasad N; Yang J; Chen SC; Ayers GD; Pawlikowski JS; Raman D; Sosman JA; Kelley M; Ecsedy JA; Shyr Y; Levy SE; Richmond A
J Natl Cancer Inst; 2016 Jun; 108(6):djv406. PubMed ID: 26719346
[TBL] [Abstract][Full Text] [Related]
11. The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis.
Shen H; McElhinny AS; Cao Y; Gao P; Liu J; Bronson R; Griffin JD; Wu L
Genes Dev; 2006 Mar; 20(6):675-88. PubMed ID: 16510869
[TBL] [Abstract][Full Text] [Related]
12. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract][Full Text] [Related]
13. Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene.
Wu L; Kobayashi K; Sun T; Gao P; Liu J; Nakamura M; Weisberg E; Mukhopadhyay NK; Griffin JD
Gene; 2004 Mar; 328():153-65. PubMed ID: 15019995
[TBL] [Abstract][Full Text] [Related]
14. Natural CD8⁺25⁺ regulatory T cell-secreted exosomes capable of suppressing cytotoxic T lymphocyte-mediated immunity against B16 melanoma.
Xie Y; Zhang X; Zhao T; Li W; Xiang J
Biochem Biophys Res Commun; 2013 Aug; 438(1):152-5. PubMed ID: 23876314
[TBL] [Abstract][Full Text] [Related]
15. Innate and adoptive immune cells contribute to natural resistance to systemic metastasis of B16 melanoma.
Umeshappa CS; Zhu Y; Bhanumathy KK; Omabe M; Chibbar R; Xiang J
Cancer Biother Radiopharm; 2015 Mar; 30(2):72-8. PubMed ID: 25714591
[TBL] [Abstract][Full Text] [Related]
16. The mastermind-like 1 (MAML1) co-activator regulates constitutive NF-kappaB signaling and cell survival.
Jin B; Shen H; Lin S; Li JL; Chen Z; Griffin JD; Wu L
J Biol Chem; 2010 May; 285(19):14356-65. PubMed ID: 20231278
[TBL] [Abstract][Full Text] [Related]
17. Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration.
Nagai H; Hara I; Horikawa T; Oka M; Kamidono S; Ichihashi M
J Invest Dermatol; 2000 Dec; 115(6):1059-64. PubMed ID: 11121142
[TBL] [Abstract][Full Text] [Related]
18. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
Alves-Guerra MC; Ronchini C; Capobianco AJ
Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
[TBL] [Abstract][Full Text] [Related]
19. Differential roles for the interferon-inducible IFI16 and AIM2 innate immune sensors for cytosolic DNA in cellular senescence of human fibroblasts.
Duan X; Ponomareva L; Veeranki S; Panchanathan R; Dickerson E; Choubey D
Mol Cancer Res; 2011 May; 9(5):589-602. PubMed ID: 21471287
[TBL] [Abstract][Full Text] [Related]
20. The notch regulator MAML1 interacts with p53 and functions as a coactivator.
Zhao Y; Katzman RB; Delmolino LM; Bhat I; Zhang Y; Gurumurthy CB; Germaniuk-Kurowska A; Reddi HV; Solomon A; Zeng MS; Kung A; Ma H; Gao Q; Dimri G; Stanculescu A; Miele L; Wu L; Griffin JD; Wazer DE; Band H; Band V
J Biol Chem; 2007 Apr; 282(16):11969-81. PubMed ID: 17317671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
